Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price rose 11.1% during mid-day trading on Monday. The stock traded as high as $0.25 and last traded at $0.25. 200 shares changed hands during trading, a decline of 99% from the average daily volume of 20,342 shares. The stock had previously closed at $0.2250.
Cell MedX Stock Performance
The stock has a 50 day moving average price of $0.22 and a 200 day moving average price of $0.30.
Cell MedX Company Profile
Cell MedX Inc is a healthcare technology company associated with the development of noninvasive wellness and therapeutic technologies. Its best-known product is the eVox System, which has been described as a biofeedback and electrotherapy device designed to support relaxation, stress management, and general wellness.
The company has also promoted technologies intended to assist with exercise, circulation, pain management, and other health-related applications. Publicly available information about the company’s current product offerings, commercial operations, geographic reach, and regulatory status is limited.
Cell MedX has historically operated in the medical technology and wellness sectors under the OTCMKTS:CMXC symbol.
See Also
- Five stocks we like better than Cell MedX
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
